Le potentiel des benzodiazépines en matière d'effets indésirables liés aux médicaments, tels que les chutes et fractures, les troubles cognitifs (…) et délires, a été bien décrit.
Réduire
Lukacisinová et al. The prevalence and prescribing patterns of benzodiazepines and Z-drugs in older nursing home residents in different Europeon countries and Israel: retrospective results from the EU SHEL TER study. BMJ Geriatrics. (2021) 21:277
Diminution
Les preuves de l’efficacité des benzodiazépines, notamment pour le traitement à long terme de l’insomnie, sont discutables.
Glass et al. Sedative hypnotics in older people with insomnio: meta-analysis of risks and benefits. BMJ. 2005:331(7526):1169
Déprescription
« Ces médicaments peuvent présenter des risques réels et il existe souvent des alternatives plus sûres. Nos résultats suggèrent fortement que nous avons besoin de stratégies pour réduire la consommation de benzodiazépines. »
Olfson et al. Benzodiazepine Use in the United States. JAMA Psychiatry. 2014 Dec 17
Implementing a patient-centred and evidence-based intervention to reduce BEnzodiazepine and sedativehypnotic use to improve patient SAFEty and quality of care.
Vidéo en vedette
Benzodiazepine Tapers in Primary Care - Kendall Shibuya, D.O.
The Seattle Science Foundation is a not for profit organization dedicated to advancing the quality of patient care through education, research, innovation and technology. As a physician driven organization, we have created a trusted community of nationally recognized experts from the world’s best medical and academic institutions.
Points forts
Choosing Wisely Canada’s National Meeting
Choosing Wisely Canada’s National Meeting will return to an in-person event on May 11 and 12, 2023. Join us in Toronto at the Globe and Mail Centre for two days of engaging keynote speakers, workshops, and breakout sessions.
